Daré Bioscience, Inc.
DARE
$1.85
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -230.55% | -384.47% | -158.33% | 94.19% | 86.56% |
| Total Depreciation and Amortization | 3,764.07% | 2,310.68% | 1,294.07% | 377.58% | 10.16% |
| Total Amortization of Deferred Charges | -- | 420.55% | -147.03% | 2,300.00% | -- |
| Total Other Non-Cash Items | -41.82% | 3.24% | 5.06% | 9.98% | 112.12% |
| Change in Net Operating Assets | -103.58% | 213.77% | 173.93% | 280.24% | 156.52% |
| Cash from Operations | -280.61% | 24.80% | -14.36% | 123.06% | 114.09% |
| Capital Expenditure | 32.77% | -20.06% | 69.15% | -13.55% | 8.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 32.77% | -20.06% | 69.15% | -13.55% | 8.96% |
| Total Debt Issued | -13.35% | -13.35% | -6.57% | -6.57% | -6.57% |
| Total Debt Repaid | -213.88% | -149.19% | -69.74% | -5.91% | -73.41% |
| Issuance of Common Stock | 4,514.20% | 1,564.90% | -89.60% | -92.94% | -95.74% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -294.72% | -101.69% | -101.69% | -101.76% | -101.73% |
| Cash from Financing | 5,337.83% | 217.30% | -96.95% | -95.91% | -97.73% |
| Foreign Exchange rate Adjustments | 110.60% | -158.52% | -191.05% | 41.79% | -607.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 73.76% | 539.12% | -473.02% | 142.01% | 121.74% |